Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
Results of PAC203: A Randomized Phase II Dose-Finding Study and Determination of the Recommended Dose of Pacritinib
1 března, 2021 3:01 pmProgram: Oral and Poster Abstracts Type: Oral Session: 634. Myeloproliferative Syndromes: Clinical: JAK Inhibitors and Combination Therapies ...
Thromboembolic Risk Reduction and High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alpha-2b in Polycythemia Vera: Results from a Randomized Controlled Study
1 března, 2021 2:09 pmProgram: Oral and Poster Abstracts Type: Oral Session: 634. Myeloproliferative Syndromes: Clinical: Emerging and Novel Targeted Therapies ...
Myeloproliferativní neoplazie – zajímavá sdělení z ASH®
1 března, 2021 2:03 pmV rámci každoročního kongresu Americké hematologické společnosti, jenž se konal ve dnech 7.–10. prosince 2019 v Orlandu na Floridě (Spojené státy americké)...
Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase II Superiority Trial
25 února, 2021 5:39 pmProgram: Oral and Poster Abstracts Session: 637. Myelodysplastic Syndromes – Clinical Studies: Poster II Hematology Disease Topics &...
Genomic Context and TP53 Allele Frequency Define Prognostic Subgroups and Response Outcomes in TP53 Mutated Myelodysplastic Syndromes
25 února, 2021 5:36 pmProgram: Oral and Poster Abstracts Session: 637. Myelodysplastic Syndromes—Clinical Studies: Poster I Hematology Disease Topics & Pathways: Diseases,...
The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase Ib Results
25 února, 2021 5:34 pmProgram: Oral and Poster Abstracts Type: Oral Session: 637. Myelodysplastic Syndromes – Clinical Studies: Combination Therapies Hematology...
Myelodysplastický syndrom – co přinesl ASH® 2019
25 února, 2021 5:30 pmNa prvém místě jmenuji dvě velmi důležité práce týkající se přesnější stratifikace nemocných a stanovení prognózy. U myelodysplastického syndromu (MDS)...
The Impact of Treatment Recommendation By Leukemia Artificial Intelligence Program (LEAP) on Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
25 února, 2021 5:27 pmProgram: Oral and Poster Abstracts Session: 632. Chronic Myeloid Leukemia: Therapy: Poster I Hematology Disease Topics & Pathways:...
RNA Splicing Defects in Cancer-Linked Genes Indicate Mutation or Focal Gene Deletion and Are Associated with TKI Resistance in CML
25 února, 2021 5:25 pmProgram: Oral and Poster Abstracts Type: Oral Session: 632. Chronic Myeloid Leukemia: Therapy: Response Monitoring and Prognosis ...
Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database
25 února, 2021 5:17 pmProgram: Oral and Poster Abstracts Type: Oral Session: 632. Chronic Myeloid Leukemia: Therapy: Clinical Trials and Outcomes ...